• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES EZ GLIDE AORTIC CANNULA, AORTIC PERFUSION CANNULA WITH DURAFLO COATING, DISPERSI; CATHETER, CANNULA AND TUBING, VASCULAR, CARDIOPULMONARY BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES EZ GLIDE AORTIC CANNULA, AORTIC PERFUSION CANNULA WITH DURAFLO COATING, DISPERSI; CATHETER, CANNULA AND TUBING, VASCULAR, CARDIOPULMONARY BYPASS Back to Search Results
Model Number EZC24TA
Device Problems Break (1069); Disconnection (1171); Nonstandard Device (1420); Detachment of Device or Device Component (2907)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 02/19/2020
Event Type  malfunction  
Manufacturer Narrative
Field corrective action (fca-146) has been initiated for the ez glide cannula separation issue.Since the device is in the vasculature, component separation may result in embolization of that portion of the device.This may require retrieval which can often be done percutaneously.Attempts for retrieval are performed to prevent complications such as infection or thrombosis, which may occur in the short or long term.Potential for injury is not remote.For devices that are used in the extra-vascular space, a separation may result in retention of the tip in the thoracic or abdominal cavity.Although less serious than an intravascular separation, there is a long term risk of infection.Attempts has been made to obtain the product.The subject device was not returned for evaluation; therefore, the reported event cannot be confirmed.The root cause of this event remains indeterminable.The device history record (dhr) review was completed and this device passed all manufacturing and sterilization inspections prior to release for distribution.Edwards will continue to monitor all events.If new information becomes available, a supplemental report will be submitted accordingly.
 
Event Description
It was reported that an ez glide aortic cannula tip came off after cannulation.When the cannula was connected to the bypass circuit, the tip/upper portion of the cannula did not immediately separated.The section was clamped with forceps/hemostat.There were no cracks or chips in the cannula that caused the disconnection.The patient was reported to be okay.
 
Manufacturer Narrative
Customer report of separated tip from ez glide cannula was confirmed.As received, the tip of the cannula was separated from main cannula body.Indications of what appeared to be bonding material were found on both the detached tip end and the cannula body.Cannula appeared bent on the cannula body at the wire-reinforced section.No other visual damage, contamination, or other abnormalities were found to the device.
 
Manufacturer Narrative
Reference capa-20-00141.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EZ GLIDE AORTIC CANNULA, AORTIC PERFUSION CANNULA WITH DURAFLO COATING, DISPERSI
Type of Device
CATHETER, CANNULA AND TUBING, VASCULAR, CARDIOPULMONARY BYPASS
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
MDR Report Key9830923
MDR Text Key207362627
Report Number3008500478-2020-00192
Device Sequence Number1
Product Code DWF
Combination Product (y/n)N
PMA/PMN Number
K123370
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Remedial Action Recall
Type of Report Initial,Followup,Followup,Followup
Report Date 02/19/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/11/2021
Device Model NumberEZC24TA
Device Catalogue NumberEZC24TA
Device Lot Number217048
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/17/2020
Initial Date Manufacturer Received 02/19/2020
Initial Date FDA Received03/13/2020
Supplement Dates Manufacturer Received03/23/2020
05/22/2020
07/23/2020
Supplement Dates FDA Received04/09/2020
05/22/2020
01/29/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-